Naturally and chemically acetylated polysaccharides: Structural characteristics, synthesis, activities, and applications in the delivery system: A review
H Li, Y Wang, P Zhao, L Guo, L Huang, X Li… - Carbohydrate Polymers, 2023 - Elsevier
Acetylated polysaccharides refer to polysaccharides containing acetyl groups on sugar
units. In the past, the acetylation modification of wall polysaccharides has been a hot …
units. In the past, the acetylation modification of wall polysaccharides has been a hot …
Barriers and opportunities for gemcitabine in pancreatic cancer therapy
AK Beutel, CJ Halbrook - American Journal of Physiology …, 2023 - journals.physiology.org
Pancreatic ductal adenocarcinoma (PDA) has become one of the leading causes of cancer-
related deaths across the world. A lack of durable responses to standard-of-care …
related deaths across the world. A lack of durable responses to standard-of-care …
Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation
The primary physiological process of respiration produces carbon dioxide (CO 2) that reacts
with water molecules which subsequently liberates bicarbonate (HCO–3) and protons …
with water molecules which subsequently liberates bicarbonate (HCO–3) and protons …
[HTML][HTML] Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
M Capula, M Perán, G Xu, V Donati, D Yee… - Drug Resistance …, 2022 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) has one of the highest incidence/death ratios
among all neoplasms due to its late diagnosis and dominant chemoresistance. Most PDAC …
among all neoplasms due to its late diagnosis and dominant chemoresistance. Most PDAC …
[HTML][HTML] Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance
S Jiang, T Deng, H Cheng, W Liu, D Shi, J Yuan… - Journal of Experimental …, 2023 - Springer
Background Gemcitabine resistance (GR) is a significant clinical challenge in pancreatic
adenocarcinoma (PAAD) treatment. Macrophages in the tumor immune-microenvironment …
adenocarcinoma (PAAD) treatment. Macrophages in the tumor immune-microenvironment …
[HTML][HTML] Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition
Background Epidermal growth factor receptor (EGFR) is an essential target for cancer
treatment. However, EGFR inhibitor erlotinib showed limited clinical benefit in pancreatic …
treatment. However, EGFR inhibitor erlotinib showed limited clinical benefit in pancreatic …
Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies
J Natu, GP Nagaraju - Cancer Letters, 2023 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is considered one of the deadliest malignancies,
with dismal survival rates and extremely prevalent chemoresistance. Gemcitabine is one of …
with dismal survival rates and extremely prevalent chemoresistance. Gemcitabine is one of …
[HTML][HTML] Current and future therapies for pancreatic ductal adenocarcinoma
Á Sally, R McGowan, K Finn, BM Moran - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic cancer is the fourth leading cause of cancer-related mortality
worldwide. The poor survival associated with this disease is due to delayed diagnosis, a …
worldwide. The poor survival associated with this disease is due to delayed diagnosis, a …
Programmable living units for emulating pancreatic tumor‐stroma interplay
MV Monteiro, M Rocha, VM Gaspar… - Advanced Healthcare …, 2022 - Wiley Online Library
Bioengineering close‐to‐native in vitro models that emulate tumors bioarchitecture and
microenvironment is highly appreciable for improving disease modeling toolboxes. Herein …
microenvironment is highly appreciable for improving disease modeling toolboxes. Herein …
[PDF][PDF] Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer
Y Li, S Tang, X Shi, J Lv, X Wu, Y Zhang, H Wang… - Cell Reports …, 2023 - cell.com
Metabolic reprogramming is known as an emerging mechanism of chemotherapy
resistance, but the metabolic signatures of pancreatic ductal adenocarcinomas (PDACs) …
resistance, but the metabolic signatures of pancreatic ductal adenocarcinomas (PDACs) …